{"schema_version":"1","generated_at":"2026-10-28T23:57:46.779Z","data_as_of":null,"url":"https://www.findmykol.com/kol/rebecca-klisovic","json_url":"https://www.findmykol.com/kol/rebecca-klisovic/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"rebecca-klisovic","name":"Rebecca Klisovic","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Atlanta","state":"GA","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1417962945","orcid":"0000-0001-6028-7347","openalex":"A5031040416"},"summary":"Rebecca Klisovic is an Oncology physician. OpenAlex indexes 189 publications with 8,709 citations (h-index 43); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":189,"cited_by_count":8709,"h_index":43,"latest_activity_year":2025,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT01685021","title":"Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat B-cell Acute Lymphoblastic Leukemia(B-ALL)","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"MorphoSys AG","source_url":"https://clinicaltrials.gov/study/NCT01685021","trial_url":"https://www.findmykol.com/trial/NCT01685021"},{"nct":"NCT00565058","title":"Combination of GTI-2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML)","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"Aptose Biosciences Inc.","source_url":"https://clinicaltrials.gov/study/NCT00565058","trial_url":"https://www.findmykol.com/trial/NCT00565058"}],"source":"trials"},"payments":{"company_count":4,"program_years":{"first":2021,"last":null},"rows_total":7,"shown":3,"withheld":4,"rows":[{"payer":"GENZYME CORPORATION","program_year":2025,"amount_usd":108.08,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1417962945"},{"payer":"Incyte Corporation","program_year":2025,"amount_usd":19.84,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1417962945"},{"payer":"Incyte Corporation","program_year":2024,"amount_usd":4110,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1417962945"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1417962945","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia","year":2022,"journal":"UNM’s Digital Repository (University of New Mexico)","status":"verified"},{"title":"Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial","year":2021,"journal":"Leukemia","source_url":"https://doi.org/10.1038/s41375-021-01179-4","status":"verified"},{"title":"Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia","year":2019,"journal":"Blood","source_url":"https://doi.org/10.1182/blood.2019002697","status":"verified"},{"title":"Selinexor in combination with decitabine in patients with acute myeloid leukemia: results from a phase 1 study","year":2019,"journal":"Leukemia & lymphoma/Leukemia and lymphoma","source_url":"https://doi.org/10.1080/10428194.2019.1665664","status":"verified"},{"title":"Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AML","year":2019,"journal":"Investigational New Drugs","source_url":"https://doi.org/10.1007/s10637-019-00786-4","status":"verified"}],"source":"works"},"contact":{"address_1":"1365 CLIFTON RD NE","city":"Atlanta","state":"GA","zip":"303221280","phone":"404-778-3932","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1417962945","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":4,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2017-08-21","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}